Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Recalls
- Mar 3, 2026 · Class II · Rising Pharma Holding, Inc.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Lots: Lot #: 1TM0524003A, Exp. Date 09/2026.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Temozolomide: every company that makes it
- Form
- capsule, oral
- Strength
- 180 mg
- Approval
- ANDA ANDA206309
- On the market since
- Oct 4, 2022
- Package NDCs
16571-820-0216571-820-4116571-820-51- Official label
- DailyMed (National Library of Medicine), updated Jul 25, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?